Pharmacolog carries out a rights issue of approximately SEK 24.1 million
Pharmacolog is expanding its product portfolio
Resolutions at Pharmacolog AB’s (publ) annual general meeting 2019
Interim report January – March 2019
Pharmacolog moves to new premises
Increased interest in the DrugLog® technology apparent after intensive exhibition weeks
Proposal for new board members
Princess Máxima Center purchases DrugLog®
Genombrott i USA – NewYork Presbyterian väljer DrugLog® (rättelse: i tidigare PM uteblev ordervärde, det har nu kompletterats nedan)
Breakthrough in US – NewYork Presbyterian chooses DrugLog®
The website uses necessary cookies to ensure the website functions properly. You can also choose to consent to cookies for statistical purposes.
Search
By requesting this documentation I agree to the terms in Pharmacologs privacy policy
